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doi:10.1016/j.ejvs.2007.12.020Abstract Objectives: To assess outcomes (wound healing, amputation and mortality) after
vacuum assisted closure (VAC) therapy of peri-vascular surgical site infections in the groin
after arterial surgery.
Design: Retrospective study.
Materials: Thirty-three groins received VAC therapy between August 2004 and December
2006 at Vascular Centre, Malmo¨ University Hospital.
Methods: Following surgical revision, VAC therapy was applied in the groin at a continuous
topical negative pressure of 125 mm Hg. The median follow up time was 16 months.
Results: Median age was 75 years. Twenty-three (70%) cases underwent surgery for lower limb
ischaemia. Intestinal flora was present in 88% of the wound cultures. Median duration of VAC
therapy was 20 days and 27 (82%) wounds healed within 55 days. One serious VAC associated
bleeding and three late false femoral artery aneurysms were reported. The median cost of
VAC treatment was 2.7% of the in-hospital costs. Synthetic vascular graft infection (nZ 21)
was associated with adverse infection-related events (nZ 9; pZ 0.012). Non-healing wounds
were associated with amputation (pZ 0.005) and death (p< 0.001).
Conclusions: VAC treated synthetic vascular graft infections in the groin were at a greater risk
of developing infection-related complications. Non-healing surgical site infections after VAC
therapy were associated with amputation and death.
ª 2008 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.a, MD, PhD, Vascular Centre,
almo¨, Sweden. Tel.: þ4640
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ty for Vascular Surgery. PublisheIntroduction
Although a relatively new technique, the application of
vacuum assisted wound closure (VAC) has expanded and
the annual number of publications on VAC has increased
rapidly. The experimental1 and clinical2 data that were
launched in 1997 have been a major breakthrough in thed by Elsevier Ltd. All rights reserved.
VAC Therapy of Peri-vascular Infections in the Groin 85wound care area. The current indications for VAC, accord-
ing to the manufacturer KCI Medical, are: Chronic open
wounds such as diabetic foot ulcer and pressure ulcers,
acute and traumatic wounds, healing of skin grafts and
open abdomen.3,4
Surgical incision in the groin and exposure of the
common femoral artery is one of the most common pro-
cedures in vascular surgery. Unfortunately, the skin in the
groin is a major reservoir of bacteria and surgical site
infections are common.5 Deep peri-vascular postoperative
wound infection in the groin after arterial surgery is some-
times related to death and/or limb loss. Apart from great
patient discomfort, in-hospital stay tends to be long and
complicated, associated with substantial costs. The inci-
dence of early wound infection including lymph fistula after
arterial surgery was reported to be 6.4% of 873 groins,6
whereas major groin complications, either formation of
false femoral artery aneurysms or infection, after recon-
structions with synthetic graft material were reported to
be 5%7 during a median follow up time of 60 months. Pa-
tients with infection of an exposed synthetic graft in the
groin often have been treated by excision of the graft or
part of the graft, with or without revascularisation with
an extra-anatomic by-pass or in situ vein-by-pass, with sub-
sequent high risk of both leg amputation and death.8
Exposed and infected grafts are sometimes treated with
muscle flap coverage and antibiotics in an attempt to try
to preserve the vascular reconstruction, but the re-
infection rate has been reported to be as high as 35%.9
VAC therapy of infected grafts in the groin only has been
described in small series but with promising results in terms
of wound healing, graft preservation and lack of complica-
tions.10e12 The aim of the present study was to assess
wound healing, amputation and mortality after VAC ther-
apy of peri-vascular surgical site infections in the groin in
a larger patient cohort.
Material and Methods
Study population and setting
The Vascular Centre, Malmo¨-Lund, Malmo¨ University Hos-
pital, is a tertiary referral centre for the southernmost part
of Sweden with a primary catchment population of approx-
imately 756 000 inhabitants (Swedish Central Bureau of
Statistics, www.scb.se). A prospective wound surveillance
registry within the department was started in March 2005
to document occurrences of post-operative surgical site in-
fections. Development of infections outside hospital are
detected either at stitch removal and then reported by dis-
trict nurses, or at the follow up visit, or in a registry that
links the operation planning programme with the wound
culture register at the Department of Microbiology. Patients
undergoing groin incisions for any vascular procedure were
given routinely three prophylactic doses of the antibiotic
dicloxacillin (Ekvacillin), where the first dose was admin-
istered at induction of anaesthesia. Cross checking for
VAC treated patients was performed through the wound
surveillance register and the lists of invoices from the man-
ufacturer of the VAC system (KCI Medical). A retrospective
study of patient records from 1st of August 2004 until 31stof December 2006 of all patients receiving VAC therapy
for peri-vascular groin infections after vascular surgery
was performed. Costs for VAC therapy and overall in-
hospital costs were estimated.
Treatment policy of VAC therapy
Patients with deep groin infections underwent surgery for
wound revision with either regional or general aaesthesia.
Wound cultures adjacent to the graft or native arteries
were obtained. VAC therapy was started the day after the
revision and a polyurethane sponge (KCI Medical, San Anto-
nio, Texas, USA) was applied with a continuous topical neg-
ative pressure of 125 mm Hg. Changes of dressings were
performed three times per week. Visible graft material
and native arteries were covered routinely with a non-
adhesive silicon-based dressing (Mepitel, Mo¨lnlycke Health
Care AB, Go¨teborg, Sweden) to minimize any possible
trauma to the vascular anastomosis or arterial reconstruc-
tion, which hypothetically could be generated by the
VAC therapy. The patients were treated in-hospital as
long as any graft material or native artery was visible. As
soon as the arterial reconstruction was covered with gran-
ulation tissue, in an otherwise fit patient, continued VAC
therapy at home, with the mini-VAC portable device
(VAC Freedom), was considered. The wound was followed
until full skin epithelialisation. Local complications were
documented from start of VAC therapy to the end of
study. Two patients with concomitant VAC therapy to
the groin and an open abdomen were excluded from this
study due to severity of abdominal disease and excess risk
of mortality.
Statistical methods
Data management and statistical analysis were performed
using the SPSS for Windows, version 14.0 (SPSS Inc., Chicago,
Illnois, USA). Differences in proportions were analysed with
the chi-square test or Fisher´s exact test. Continuous vari-
ables were expressed in median and range. The costs in
Swedish crowns (SEK) were transferred into the Euro cur-
rency (exchange rates from 28th of August; www.forex.se).
P-values< 0.05 were considered significant.
Results
Patients
The median age of the 28 patients was 75 years (range 48e
88 years). Almost half, 14/23 (42%) of the infected groins
were in patients with diabetes mellitus. Primary indications
for vascular intervention were critical lower limb ischaemia
(nZ 23), abdominal aortic aneurysm (nZ 7) and coronary
insufficiency (nZ 3). The following procedures were fol-
lowed by peri-vascular groin infection: Thrombendarterec-
tomy of the common femoral artery (nZ 8) and/or
profunda femoris artery (nZ 2), femoral e femoral cross-
over (nZ 3), replacement of the common femoral artery
by a interposition bypass graft (nZ 3), femoral embolec-
tomy (nZ 3), femoro-popliteal bypass (nZ 3), percutane-
ous coronary intervention (nZ 3), endovascular repair of
Table 2 VAC therapy characteristics
VAC therapy n (%)
Treated groins/patients 33/28
Exposed and infected synthetic grafts 21 (64)
Duration of therapy
Days 20 (3e119)
Number of dressing changes 7 (1e40)
Proportion of wounds treated
outside hospital
16 (48)
Results
Proportion of healed wounds 27 (82)
Time to full skin epithelialisation (days) 55 (25e217)
(nZ 27)
86 S. Svensson et al.abdominal aortic aneurysm (EVAR) (nZ 7) and aortobife-
moral by-pass graft (nZ 1). Among the 21 patients where
synthetic graft material was inserted in the femoral artery,
nine had polytetraflouro ethylene (PTFE, Gore-Tex) by-
pass grafts and 12 had Dacron (Vascutek) patches. Median
hospital stay was 23 days (range 3e82).
Microbiology
Bacteria pertaining to the intestinal flora were present in
the majority, 88% (29/33) of the wounds in the groin
(Table 1). The most common single bacteria was Enterococ-
cus faecalis, which was isolated in 12 (36%) groins. Staphy-
lococcus aureus was present in five groins (15%). In view of
the results of the final bacterial resistance pattern, the
initial antibiotic therapy was inadequate in 18 (55%) cases.
VAC therapy
VAC therapy was applied to 33 infected groins (Table 2), of
whom 21 (64%) were men. Exposed and infected synthetic
and vein grafts were present in 21 (64%) and three (9%)
groins, respectively. Twenty-seven (82%) infected groins
healed (Table 3). Among the six (18%) unhealed wounds,
four patients died as a consequence of infection. Concom-
itant VAC therapy of non-inguinal wounds was applied inTable 1 Microbiology: results of the wound cultures in the
33 groins
N
Skin flora
Stafylococcus aureus 5
Stafylococcus epidermidis 5
Stafylococcus species 1
Streptococcus 2
Skin flora 13
Intestinal flora
Enterococcus faecalis 12
Pseudomonnas aeruginosa 7
Enterococcus faecium 6
Proteus mirabilis 4
Eschericia coli 3
Enterobacter cloacae 3
Enterococcus species 2
Klebsiella oxytoca 2
Proteus vulgaris 1
Klebsiella pneumoniae 1
Citrobacter freundii 1
Moraxella Catarrhalis 1
Clostridium Ramosum 1
Bacteroides Fragilis 1
Anaerobic bakteriae 10
Enterococcus 7
Faecal flora 6
Mixture of flora 3
Sum 97five patients: after fasciotomies in the lower leg (nZ 1), in-
fected synthetic graft in the upper leg (nZ 1), infected
vein graft in the lower leg (nZ 1), infected synthetic graft
in the abdominal wall (nZ 1) and a non-surgical site foot
ulcer (nZ 1).
Costs
The median in-hospital cost for the patients was 26,022
Euros (4078e136 330). The median total cost per patient for
the VAC treatment, including the out patient treatments,
was 1,299 Euros (210e7416). The cost of VAC treatment in
relation to the in-hospital cost in those 15 patients that
completed the VAC therapy in-hospital was 2.7% (range
0.6e9.9%).
VAC associated bleeding
VAC associated bleeding occurred in two hospital patients:
One patient underwent emergency surgery for a synthetic
graft infection in the groin and intermittent bleeding
from a false femoral artery aneurysm, and the synthetic
patch was replaced by a vein patch. Due to persistent infec-
tion, revision of the wound was made, followed by VAC
therapy, 10 days later. Four days after commencing the
VAC therapy, the patient experienced a severe bleeding
episode from the groin with circulatory instability. There
was a rapid swelling of the left groin and the vacuum sys-
tem was occluded after collecting 1 litre of blood in the
canister. An emergency operation revealed a disruption of
the necrotic and infected vein patch. The vein patch was
replaced by a vein interposition graft, harvested from the
superficial femoral vein, and coverage was performed
with a sartorius muscle flap. The patient recovered well.
The second patient initially had undergone direct suture
of the common femoral artery, because of false femoral
artery aneurysm after an EVAR procedure, followed by
a sartorius muscle flap. VAC therapy followed and 14 days
later moderate arterial bleeding from the wound occurred
and the VAC system was occluded due to aggregation of
coagulated blood in the groin. The exact source of this
arterial bleeding was not identified. VAC therapy was dis-
continued and it was decided to seal the common femoral
artery, the following day, by coiling the superficial femoral
Table 3 Predictors for complete wound healing, amputation and mortality during follow-up after VAC therapy of 33 peri-
vascular infections in the groins after vascular surgery
Groins (%) Complete wound
healing (%)
Amputation (%) Mortality (%)
VAC therapy (all) 33 27 (82) 6 (18) 9 (27)
Comorbidity
Age 80 years 10 (30) 9/10 (90) 3/10 (30) 2/10 (20)
Women 12 (36) 10/12 (83) 4/12 (33) 3/12 (25)
Diabetes Mellitus 14 (42) 11/14 (78) 4/14 (29) 3/14 (21)
Lower limb ischemia 23 (70) 19/23 (83) 4/23 (17) 5/23 (22)
Graft infection
All 24 (73) 18/24 (75) 6/24 (25) 8/24 (33)
Synthetic 21 (64) 15/21 (71) 6/21 (29) 7/21 (33)
Venous 3 (9) 3/3 (100) 0/3 (0) 0/3 (0)
Microbiology
Intestinal flora 29 (88) 23/29 (79) 5/29 (17) 8/29 (28)
Stafylococcus Aureus 5 (15) 5/5 (100) 0/5 (0) 1/5 (20)
Wound not healed 6 (18) e 4/6 (67)** 6/6 (100)*
Amputation 6 (18) e e 4/6 (67)***
P-values< 0.05 are denoted. *p< 0.001, **pZ 0.005, ***pZ 0.034.
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artery to the external iliac artery through vascular access
from right brachial artery. VAC therapy was restarted on
the first postoperative day and the wound healed.
Infection-related local complications after VAC
therapy
Four patients experienced late infection-related complica-
tions. One patient was bleeding intermittently from an
infected false femoral artery aneurysm one month after
completion of VAC therapy. The wound was not com-
pletely healed and at emergency operation the synthetic
graft was observed to be partially disconnected from the
arterial wall. The graft material was removed and the ar-
tery was repaired with an arterial patch. The wound healed
without further VAC therapy and the follow-up was
uneventful.
The second patient was admitted with acute bleeding
from the groin due to a false femoral artery aneurysm 6
months after complete wound healing of an infected
femoral-femoral bypass graft. All visible synthetic graft
material in the groin was removed during an emergency
operation, and in a second operation, an above-knee
amputation for severe ischaemia of the leg was performed.
The third patient had a false femoral artery aneurysm,
without any bleeding episodes, 3 months after completion
of wound healing. The synthetic patch in the common
femoral artery was removed and the external iliac and
profunda femoral arteries were ligated, followed by a fem-
oral-popliteal crossover bypass with synthetic material.
However, at a second operation, a below-knee amputation
was necessary due to occlusion of the bypass, and at a third
operation, removal of the infected bypass was necessary.
The fourth patient developed a superficial wound
infection, emanating from the wound scar in the groin, 6months after completion of wound healing. The patient
recovered well after antibiotic therapy.
In total, synthetic grafts were removed in 3 cases and
vein graft in one case. The removal rate of grafts was 4/24
(17%).
Amputation and mortality
The median follow up time was 16 months. Six (18%)
patients were amputated (Table 3), three amputations
were during the same hospitalisation period as the VAC
treatment. The level of amputation was ex-articulation of
the hip joint (nZ 1), above-knee (nZ 3) and below-knee
(nZ 2). There was a lower healing rate following synthetic
graft infection (nZ 21), but this was only of borderline sig-
nificance (pZ 0.06). There was a borderline higher ampu-
tation rate associated with synthetic grafts (pZ 0.06),
but mortality among those with synthetic grafts was not
increased (pZ 0.43). When summarizing the infection-
related events, synthetic graft infection was found to be
associated with adverse outcome in a total of nine (43%)
groins (pZ 0.012), in terms of no wound healing (nZ 6),
formation of false femoral artery aneurysm (nZ 3), super-
ficial wound infection (nZ 1) and amputation (nZ 6). The
wounds in all 12 patients without synthetic graft infection
healed uneventfully. Non-healing wounds in the groin
were associated with amputation (pZ 0.005) and death
(p< 0.001; Table 3). Amputation was associated with death
(pZ 0.034). The amputation-free survival rate during fol-
low-up was 67% (22/33).
Discussion
The wound healing rate of the VAC treated peri-vascular
surgical site infections in the groin was high, 82%, despite
88 S. Svensson et al.a high proportion of patients with diabetes mellitus, crit-
ical lower limb ischaemia, synthetic graft infection and
inadequate antibiotic therapy. The incidence of synthetic
graft infection was 64%, and the occurrence of adverse
infection-related events was high, 43%, in this subgroup
of 21 patients, whereas no such complications occurred
among the 12 patients without synthetic graft infection.
Wound healing seems to be crucial in these patients,
since a non-healing wound was associated with both
amputation and death. The crude 1-year mortality rate
in the present study is similar to the reported 1-year
mortality rate of 24% in patients with critical limb ischae-
mia without a concomitant graft infection from the same
city.13
The manufacturers of the VAC system, KCI Medical, do
not recommend VAC therapy for exposed vessels or vas-
cular reconstructions.14 In cases of graft infection, graft
removal and amputation is an unattractive treatment op-
tion. In view of the encouraging reports of VAC treat-
ment,15,16 we have adopted this technique for wound
healing in an attempt to preserve the vascular reconstruc-
tions. Arterial bleeding during VAC therapy of these deep
groin wounds occurred in two cases, a complication which
not has been described in any of the previous series.10e12
However, it seems that a few centres, apart from ours,
also have experienced VAC associated serious bleeding
complications.17 The bleeding episodes in the present
study were mediated through the polyurethane sponge,
which is firmly attached to the wound during suction and
has larger pores for greater drainage capability, whereas
the polyvinyl alcohol sponges used in the other centre17
are considered more lenient, with smaller pores and less
in-growth characteristics. However, it is very likely that
the serious bleeding that occurred during VAC therapy
in our patients, would have occurred spontaneously at
a later date, and that the negative suction applied just
revealed the non-durable vascular reconstruction at an
earlier time point.
The incidence of both superficial and deep surgical site
infections in the groin after vascular surgery was high during
the study period, which might reflect an efficient wound
surveillance register.18 However, it is likely that there also
exist a problem with hygienic patient care. For instance, in-
testinal flora predominated in the wound cultures, whereas
staphylococcus was prevalent in 15% of the groins. Several
explanations for the high incidence of intestinal flora are
possible: First, dicloxacillin is used as a preventive measure
against evolution of staphylococcus infection. Secondly, the
groin is considered as an unclean area located adjacent to
the uro-anal region. Moreover, non-surgical ulcer infections
on the same hospital ward also have been studied during the
same period within the wound infection registry, showing
a majority of intestinal flora among the wound cultures.18
Hence cross- contamination of patients awaiting elective
surgery at the ward may have occurred, with subsequent de-
velopment of infection in some. In view of the microbiology
results, we have changed our routine for the initial treat-
ment of wound infections in the groin, and replaced
dicloxacillin with more broad-spectrum antibiotic therapy,
such as piperacillinþ tazobactam (Tazocin) or trimeto-
primþ sulfametoxazol (Eusaprim) until the final wound
culture results are obtained.In cases of deep groin infection, VAC therapy alone
cannot replace the initial surgical wound debridement
and thorough surgical revision is a key promoter in facilitat-
ing the wound healing effects of VAC therapy.19 The VAC
system seems to be able to rapidly clear the wound of pos-
itive cultures.12 However, infection-related major compli-
cations in terms of formation of false femoral artery
aneurysm during follow-up occurred in 3 patients in the
present study. A previous series of 24 patients with a follow
up time of 12 months did not report any late complica-
tions.12 This discrepancy may be explained by differences
in patient selection and grading of the depth of infection,
even though the authors claim that only patients with Szila-
gyi grade III infections were enrolled. However, the set up
of the vacuum systems were not identical as our patients
received treatment through a polyurethane sponge with
a continuous negative pressure of 125 mm Hg, whereas
the other patient cohort12 received therapy through a poly-
vinyl alcohol sponge with much higher negative pressure,
fluctuating between 400 and 600 mm Hg. Further research
is needed on the relationship between VAC therapy char-
acteristics and bacterial clearance from synthetic vascular
grafts. Until proven otherwise, manifest infection of a syn-
thetic vascular graft should be considered a significant risk
factor for the development of false femoral artery aneu-
rysm,20 even after an apparently successful treatment
period with VAC.
The costs for the VAC treatment in relation to the in-
hospital care were low. An increased awareness about the
possibility of either continuing VAC therapy outside hospi-
tal or performing secondary skin suture in a vertical mat-
tress fashion manner after 14 days of VAC12 may further
reduce the cost. VAC therapy commonly is reported as
a cost-effective treatment, but few studies and no random-
ized trials can confirm this. There is an analysis of a large
retrospective comparative case control series, which
favours the VAC therapy in terms of lower costs due to
much faster healing time.21 Some groin wounds after vascu-
lar surgery leak large amount of lymph fluid for several
weeks, and the VAC system provides superior control sys-
tem of this leakage11 in comparison to conventional dress-
ings. In such circumstances, conventional dressings are
cost-ineffective and hampered by frequent changes of
dressings every day, skin irritation of excessive fluid, and
frequent changes of patient and bed linen. Moreover, pa-
tient care is difficult to manage outside hospital with in-
creased risk of immobilization.
The limitations of the present study are attributed to its
retrospective nature and the lack of a comparative group.
Therefore a prospective randomized trial has started re-
cently in our unit to evaluate the usefulness of VAC ther-
apy compared to best alternative conservative treatment,
in terms of wound healing, quality of life and cost
effectiveness.
VAC therapy of peri-vascular groin infections may be
considered the first choice of therapy leading to a high
rate of preservation of vascular graft reconstructions.
VAC treated synthetic vascular graft infections in the groin
are at greater risk of developing infection-related compli-
cations. Non-healing surgical site infections after VAC
therapy were associated with an increased risk of amputa-
tion and death.
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